Regeneron Pharmaceuticals Inc

REGN Company Profile

Current Price

$661.39

Sector

Healthcare

Industry

Biotechnology

Business Overview

Company profile information not available.

Company Information

Stock SymbolREGN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Market Cap$59.10B
P/E Ratio13.91

Analyze REGN Stock

Get comprehensive financial analysis, real-time data, and AI-powered insights

Frequently Asked Questions

What does REGN do?

Company profile information not available.

What industry is REGN in?

Regeneron Pharmaceuticals Inc operates in the Biotechnology industry within the Healthcare sector.

Where is REGN headquartered?

Company headquarters information for REGN is available through our platform.

How many employees does REGN have?

Employee count information for REGN will be updated when available.

Who is the CEO of REGN?

Executive leadership information for REGN is available through company filings and our platform.

When was REGN founded?

Company founding date information for REGN is available through our platform.

What is REGN's business model?

Regeneron Pharmaceuticals Inc operates in the Biotechnology industry generating revenue through its core business operations in the Healthcare sector. View our detailed financial analysis for revenue breakdown and business segments.

Is REGN publicly traded?

Yes, REGN (Regeneron Pharmaceuticals Inc) is a publicly traded company listed on NASDAQ. You can view real-time stock quotes, financial statements, and analysis on our platform.

Disclaimer: Company information is sourced from public filings and data providers. Information may change as companies update their corporate structure, operations, and disclosures. Always verify current information through official company sources and SEC filings.

Explore Categories